Dumping Syndrome clinical trials

The registry lists 20 studies for Dumping Syndrome across more than 10 countries. 3 are recruiting or about to start. 12 of them are mainly about Dumping Syndrome (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-03.

Get an email when these change. Save the Dumping Syndrome studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 11
Recruiting: 3
Status unknown: 3
Active, not recruiting: 2
Terminated: 1

Phase

Phase 4: 3
Phase 2: 3

Where

Belgium: 5
France: 5
Netherlands: 3
Greece: 3
Brazil: 2
Korea, Republic of: 2

Who runs them

University Hospital, Lille (3) · Cambridge University Hospitals NHS Foundation Trust (2) · Universitaire Ziekenhuizen KU Leuven (2) · Larissa University Hospital (1) · National Cancer Center, Korea (1) · Samsung Medical Center (1) · Technological Educational Institute of Thessaly (1) · RECORDATI GROUP (1)

What is being tested here

Drugs under test in Dumping Syndrome studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Pasireotide	0	0	3
Glucose	0	0	1
Empagliflozin	0	0	1
Lanreotide	0	0	1
Somatostatin	0	0	1
Rifaximin	0	0	1
Lanreotide Long-Acting Aqueous Gel	0	0	1

Coming up

0phase 3 studies under way

1study finishes main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The study

Nov 2026Dumping Syndrome and Esophageal Atresia · University Hospital, Lille

Who these studies take

Of the 3 Dumping Syndrome studies recruiting now, 1 (33%) set no upper age limit and 2 (67%) stop at 75 or younger. 1 (33%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 3
Age	Women	Men
10	0 (0%)	0 (0%)
18	2 (67%)	2 (67%)
30	2 (67%)	2 (67%)
40	2 (67%)	2 (67%)
50	2 (67%)	2 (67%)
65	2 (67%)	2 (67%)
75	1 (33%)	1 (33%)
85	1 (33%)	1 (33%)

Across all 20 studies, recruiting or not: 30% stop at 75 or younger and 25% at 65; 20% take children; 0% are for women only and 0% for men only; 10% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Feasibility Study of Middle Segmental Gastrectomy (MSG) for Gastric Cancer.Oct 27, 2026NCT07899697

Studies

Recruiting first, then most recently updated. Showing 20 of 20. search them.